ConductScience.org, home

Paper38947372

Strategies of Pharmacological Repositioning for the Treatment of Medically Relevant Mycoses.

Gómez-Gaviria M and 3 others. Infect Drug Resist, 2024. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Strategies of Pharmacological Repositioning for the Treatment of Medically Relevant Mycoses. Papers, record 38947372. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38947372

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Strategies of Pharmacological Repositioning for the Treatment of Medically Relevant Mycoses.
PubMed
Journal
Infect Drug Resist
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
2.2, provisional
iCite
Revised in PubMed
2024-07-02
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gómez-Gaviria MManuela
2Contreras-López LMLuisa M
3Aguilera-Domínguez JIJulieta I
4Mora-Montes HMHéctor Mhttps://orcid.org/0000-0001-6973-0595

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References127

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133821795Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane.Elife2021https://conductscience.org/library/papers/33821795PubMed
234152816In Vitro and In Vivo Antifungal Activity of Buparvaquone against Sporothrix brasiliensis.Antimicrob Agents Chemother2021https://conductscience.org/library/papers/34152816PubMed
328685162In Vivo Indicators of Cytoplasmic, Vacuolar, and Extracellular pH Using pHluorin2 in Candida albicans.mSphere2017https://conductscience.org/library/papers/28685162PubMed
434368017Miltefosine Against Scedosporium and Lomentospora Species: Antifungal Activity and Its Effects on Fungal Cells.Front Cell Infect Microbiol2021https://conductscience.org/library/papers/34368017PubMed
519109335Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus.J Antimicrob Chemother2009https://conductscience.org/library/papers/19109335PubMed
623931748Mitochondrial dysfunction indirectly elevates ROS production by the endoplasmic reticulum.Cell Metab2013https://conductscience.org/library/papers/23931748PubMed
729653129Delivering drugs to the lungs: The history of repurposing in the treatment of respiratory diseases.Adv Drug Deliv Rev2018https://conductscience.org/library/papers/29653129PubMed
833052959Identification of two potential inhibitors of Sporothrix brasiliensis and Sporothrix schenckii in the Pathogen Box collection.PLoS One2020https://conductscience.org/library/papers/33052959PubMed
925057459Drug repurposing and human parasitic protozoan diseases.Int J Parasitol Drugs Drug Resist2014https://conductscience.org/library/papers/25057459PubMed
108667037In-vitro activity of commonly used antifungal agents in the presence of rifampin, polymyxin B and norfloxacin against Candida albicans.J Chemother1995https://conductscience.org/library/papers/8667037PubMed
1119538521HIV protease inhibitors differentially inhibit adhesion of Candida albicans to acrylic surfaces.Mycoses2010https://conductscience.org/library/papers/19538521PubMed
1224197921Endemic mycoses in immunocompromised hosts.Curr Infect Dis Rep2013https://conductscience.org/library/papers/24197921PubMed
1332942693Current Insights on Antifungal Therapy: Novel Nanotechnology Approaches for Drug Delivery Systems and New Drugs from Natural Sources.Pharmaceuticals (Basel)2020https://conductscience.org/library/papers/32942693PubMed
1410855824The pharmacology of halogenated salicylanilides and their anthelmintic use in animals.J S Afr Vet Assoc1999https://conductscience.org/library/papers/10855824PubMed
1528702025Cellular and Molecular Defects Underlying Invasive Fungal Infections-Revelations from Endemic Mycoses.Front Immunol2017https://conductscience.org/library/papers/28702025PubMed
1620707818The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents.FEMS Yeast Res2010https://conductscience.org/library/papers/20707818PubMed
1732253207In Vitro and In Vivo Study on the Synergistic Effect of Minocycline and Azoles against Pathogenic Fungi.Antimicrob Agents Chemother2020https://conductscience.org/library/papers/32253207PubMed
1823457073Interaction of miltefosine with the lipid and protein components of the erythrocyte membrane.J Pharm Sci2013https://conductscience.org/library/papers/23457073PubMed
1915329361Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against Leishmania amazonensis.J Antimicrob Chemother2004https://conductscience.org/library/papers/15329361PubMed
2034071195Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans-In Silico, In Vitro and In Vivo Approaches.J Fungi (Basel)2021https://conductscience.org/library/papers/34071195PubMed

See all 127 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42794569WHO Critical Priority Fungi: A Comprehensive Review of Antifungal Resistance, Emerging Therapeutic Strategies, and the Potential of Antifungal Peptides.Int J Mol Sci2026https://conductscience.org/library/papers/42794569PubMed
42384304Preventive action of ketamine alone and in combination with antifungals on Candida biofilm formation in catheters.Int Microbiol2026https://conductscience.org/library/papers/42384304PubMed
42353721Exploring the Antifungal, Antibiofilm, and Wound Healing In Vitro Properties of N-(4-Methoxycinnamoyl)-Anthranilic Acid as a Supportive Strategy for Ocular Fungal Infections.Antibiotics (Basel)2026https://conductscience.org/library/papers/42353721PubMed
41375247Iodinated Near-Infrared Dyes as Effective Photosensitizers for the Photodynamic Eradication of Amphotericin B-Resistant Candida Pathogens.Molecules2025https://conductscience.org/library/papers/41375247PubMed
41162496Innovative green niosomal piperlongumine as a novel topical treatment for dermatophytosis in guinea pigs model.Sci Rep2025https://conductscience.org/library/papers/41162496PubMed
40670739In vivo efficacy of atorvastatin in the treatment of Tinea pedis: stepping forward into drug repositioning.J Antibiot (Tokyo)2025https://conductscience.org/library/papers/40670739PubMed
39728367New Ground in Antifungal Discovery and Therapy for Invasive Fungal Infections: Innovations, Challenges, and Future Directions.J Fungi (Basel)2024https://conductscience.org/library/papers/39728367PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38947372

GET https://conductscience.org/api/papers/v1/38947372/references?page=2